Cancer research

Phase I trial of a 90-minute infusion of the fusion toxin DAB486IL-2 in hematological cancers.

Cancer research

LeMaistre CF, Craig FE, Meneghetti C, McMullin B, Parker K, Reuben J, Boldt DH, Rosenblum M, Woodworth T

Pages